Article Versions Notes

Olid MC, Hidalgo M, Prieto I, Cobo A, Martínez-Rodríguez AM, Segarra AB, Ramírez-Sánchez M, Gálvez A, Martínez-Cañamero M. Evidence Supporting the Involvement of the Minority Compounds of Extra Virgin Olive Oil, through Gut Microbiota Modulation, in Some of the Dietary Benefits Related to Metabolic Syndrome in Comparison to Butter. Molecules. 2023; 28(5):2265. https://doi.org/10.3390/molecules28052265

Olid, María Collado, Marina Hidalgo, Isabel Prieto, Antonio Cobo, Ana M. Martínez-Rodríguez, Ana Belén Segarra, Manuel Ramírez-Sánchez, Antonio Gálvez, and Magdalena Martínez-Cañamero. 2023. "Evidence Supporting the Involvement of the Minority Compounds of Extra Virgin Olive Oil, through Gut Microbiota Modulation, in Some of the Dietary Benefits Related to Metabolic Syndrome in Comparison to Butter" Molecules 28, no. 5: 2265. https://doi.org/10.3390/molecules28052265

Olid, M. C., Hidalgo, M., Prieto, I., Cobo, A., Martínez-Rodríguez, A. M., Segarra, A. B., Ramírez-Sánchez, M., Gálvez, A., & Martínez-Cañamero, M. (2023). Evidence Supporting the Involvement of the Minority Compounds of Extra Virgin Olive Oil, through Gut Microbiota Modulation, in Some of the Dietary Benefits Related to Metabolic Syndrome in Comparison to Butter. Molecules, 28(5), 2265. https://doi.org/10.3390/molecules28052265